Akebia Therapeutics (AKBA) Price to Sales (2017 - 2026)
Akebia Therapeutics' Price to Sales came in at 1.41 for Q2 2026, down 69.9% from 4.70 a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Price to Sales (2017 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics' Price to Sales was 1.81, down 32.2% from FY2024.
- Going back by year, Price to Sales was 2.67 in FY2024 (+115.1%), 1.24 in FY2023 (+239.5%), 0.37 in FY2022 (-80.7%) and 1.89 in FY2021 (+34.3%).
- The Q2 2026 figure represents the lowest quarterly Price to Sales since Q2 2024.
- Year-over-year, Price to Sales has declined for three consecutive quarters, with growth averaging 54.0% over the last eight quarters.
- The fastest year-over-year change in Price to Sales over five years came in Q3 2023 (growth of 452.9%), and the weakest in Q2 2022 (a decline of 92.5%).
- Business Quant data shows AKBA's Price to Sales at 1.60 (Q1 2026), 1.81 (Q4 2025) and 3.22 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 |
| Mar 31, 2026 | 1.60 |
| Dec 31, 2025 | 1.81 |
| Sep 30, 2025 | 3.22 |
| Jun 30, 2025 | 4.70 |
| Mar 31, 2025 | 2.72 |
| Dec 31, 2024 | 2.67 |
| Sep 30, 2024 | 1.64 |
| Jun 30, 2024 | 1.23 |
| Mar 31, 2024 | 2.05 |
| Dec 31, 2023 | 1.24 |
| Sep 30, 2023 | 1.11 |
| Jun 30, 2023 | 0.86 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.37 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.22 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 1.89 |
| Sep 30, 2021 | 2.39 |
API Access
Akebia Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();